Atanas G. Atanasov

Atanas G. Atanasov is Principle Investigator of Ludwig Boltzmann Institute for Digital Health and Patient Safety (LBI-DHPS) at Medical University of Vienna (Austria), Adjunct Professor at IGAB PAS (Poland), and Editor-in-Chief of Current Research in Biotechnology (#CRBIOTECH, Elsevier).

Dr Atanasov holds MSc degree in Biotechnology, PhD degree in Biochemistry, and Habilitation (Privatdozent (PD) degree) in Pharmaceutical Biology (from the University of Vienna, Austria). He has published >200 papers in the areas of Molecular Medicine, Digital Health, Open Innovation, Biotechnology, Natural Products, Science Communication, and Molecular Pharmacology.  Moreover, Dr Atanas G. Atanasov is a distinguished promoter of digital science communication (including use of social mediae.g., a >100 000-followers Twitter channel) and open innovation (e.g., through the executive administration of open innovation platforms focused on Digital Health and Patient Safety (#DHPSP) and on Natural Product Research (#INPST)).